Irfan Qayoom
Overview
Explore the profile of Irfan Qayoom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gupta S, Qayoom I, Mairal A, Singh S, Kumar A
ACS Infect Dis
. 2024 Oct;
10(11):3994-4008.
PMID: 39469832
The management of bone and joint infections is a formidable challenge in orthopedics and poses a global health concern. While clinical management emphasizes infection prevention and complete eradication, an effective...
2.
Srivastava E, Qayoom I, Kumar A
ACS Appl Mater Interfaces
. 2024 Oct;
16(44):59738-59751.
PMID: 39467155
Diabetes has currently acquired the status of epidemic worldwide, and among its various pathological consequences like retinopathy and nephropathy, bone fragility fractures from diabetic osteopathy occurs in later stages and...
3.
Debnath K, Qayoom I, ODonnell S, Ekiert J, Wang C, Sanborn M, et al.
bioRxiv
. 2024 Apr;
PMID: 38585943
Tissue barriers must be rapidly restored after injury to promote regeneration. However, the mechanism behind this process is unclear, particularly in cases where the underlying extracellular matrix is still compromised....
4.
Qayoom I, Prasad A, Srivastava E, Fazili K, Nussler A, Kumar A
Biomater Adv
. 2023 Dec;
157:213714.
PMID: 38096647
Current treatment approaches in clinics to treat the infectious lesions have partial success thus demanding the need for development of advanced treatment modalities. In this study we fabricated an organic-inorganic...
5.
Gupta A, Mehta S, Qayoom I, Gupta S, Singh S, Kumar A
Int J Pharm
. 2023 Jun;
642:123110.
PMID: 37302672
Developing biofunctionalized ceramic bone substitutes with phytobioactives for their sustained delivery is highly desired to enhance the osteo-active potential of ceramic bone substitutes, reduce the systemic toxicity of synthetic drugs,...
6.
Gupta S, Qayoom I, Gupta P, Gupta A, Singh P, Singh S, et al.
ACS Appl Mater Interfaces
. 2023 Feb;
PMID: 36749176
Developing advanced methods for effective bone reconstructive strategies in case of critical bone defects caused by tumor resection, trauma, and other implant-related complications remains a challenging problem in orthopedics. In...
7.
Qayoom I, Srivastava E, Kumar A
Biomater Adv
. 2022 Oct;
142:213133.
PMID: 36215747
Bone and joint infections pose a serious challenge in the orthopedic medical condition which presents a major health care problem and economic burden to the patients. The current treatment strategies...
8.
Teotia A, Qayoom I, Singh P, Mishra A, Jaiman D, Seppala J, et al.
ACS Appl Bio Mater
. 2022 Jan;
4(4):3716-3726.
PMID: 35014456
Ceramic biomaterials are promising alternatives to bone autografts. However, limited bioactivity affects their performance. Therefore, bioactive molecules and cells are often added to enhance their performance. Exosomes have emerged as...
9.
Singh P, Gupta A, Qayoom I, Singh S, Kumar A
Biomed Pharmacother
. 2021 Jul;
130:110754.
PMID: 34321168
Bone injuries occur due to various traumatic and disease conditions. Healing of bone injury occurs via a multi-stage intricate process. Body has the potential to rectify most of the bone...
10.
Mishra A, Singh P, Qayoom I, Prasad A, Kumar A
J Mater Chem B
. 2021 Jul;
9(32):6281-6309.
PMID: 34286815
Exosomes are naturally occurring nanovesicles of endosomal origin, responsible for cellular communication. Depending on the cell type, exosomes display disparity in the cargo and are involved in up/down regulation of...